Killer of the Killer—Myeloperoxidase Inhibitor from Siddha System of Medicine

Authors

  • Amruthavalli G. V.
  • Aruna V.
  • Gayathri R.

Abstract

Two proprietary siddha medicines such as NiKu plus and S.I.V.A. herbal drops were evaluated for myeloperoxidase (MPO) inhibition by in vitro enzyme assay. The MPO plays an important role in the predisposition of various complications both in diabetes mellitus (DM) and in psoriasis. Both NiKu plus and S.I.V.A. herbal drops showed high inhibitory activity of MPO. The findings suggest that regular use of NiKu and S.I.V.A. is must for patients suffering from DM and psoriasis.

 

Keyword: myeloperoxidase, medicine, inhibitor

 

Cite this Article

Amruthavalli GV, Aruna V, Gayathri R. Killer of the Killer—Myeloperoxidase Inhibitor from Siddha System of Medicine. Research & Reviews: A Journal of Pharmacology. 2018; 8(3): 31–34p.

 

Downloads

Published

2019-01-02

Issue

Vol. 8 No. 3 (2018)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.